| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8439251 | European Journal of Cancer | 2018 | 9 Pages |
Abstract
DNA repair genes may play a significant role in the pharmacogenetics of aCRC. Our data suggest that both common and rare DPYD variants may be associated with toxicity to fluoropyrimidine-based chemotherapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ayman Madi, David Fisher, Timothy S. Maughan, James P. Colley, Angela M. Meade, Julie Maynard, Vikki Humphreys, Harpreet Wasan, Richard A. Adams, Shelley Idziaszczyk, Rebecca Harris, Richard S. Kaplan, Jeremy P. Cheadle,